Fact CheckerSign in

NCT06412237Completed

An Exploratory Study of a Wearable Robotic Hand Orthosis

An Exploratory Study of a Wearable Robotic Hand Orthosis in the Chronic Stroke Population in Singapore: A Clinic to Home Feasibility Trial

Source: ClinicalTrials.gov · Last updated 7 Oct 2026

Brief summary (registry, in English)

Upper limb deficits usually remain in 75% of the stroke survivors despite completing full rehabilitation. This is due to lack of effectiveness of rehabilitation and the degree of support and resources available. In this study, the investigators plan to study the use of assistive technologies in chronic stroke survivors.

Status (registry)
Completed
Study type
Interventional
Enrollment
8 (actual)
First submitted
8 May 2024
Start date
1 Jun 2024
Primary completion date
27 Jan 2026
Lead sponsor
Tan Tock Seng Hospital
Diseases
Stroke
NCT number
NCT06412237

What you commit to

  • Study type: Interventional
  • Participants enrolled: 8
  • From 1 Jun 2024 to the primary completion date, 27 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Local factors which may be worsened by intensive arm therapy: spasticity of Modified Ashworth Scale grades 3-4, skin wounds, shoulder pain Pain Scale \>5/10, active/non-united fractures or arthritis or fixed joint/tissue flexion contractures of shoulder, elbow, wrist or fingers incompatible with tenoexo interface.

Other illness

  • Non-stroke related causes of arm motor impairment.
  • Has unstable or terminal medical conditions which may affect participation (e.g.: unresolved sepsis, postural hypotension, end stage renal failure, cancer, retroviral disease, on immunosuppressive therapy) or anticipated life expectancy of \<1 year due to malignancy or neurodegenerative disorder.

Other

  • Patient with severe cognitive, perceptual (include hemi-neglect), and/or emotional-behavioural issues that preclude participation.
  • Experiencing moderate to severe levels of pain (Numerical Vertical Pain Scale \> 5).
  • Is pregnant or breast feeding. Neither the tenoexo nor the IMUs have been tested to evaluate the usage with pregnant and/or breast feeding mothers. Further, due to the length of the study, pregnancy may make it difficult to follow the study schedule.
  • Have a pacemaker. Magnets are used throughout the system.

Who the study is looking for

  • Patient with first ever clinical stroke (ischaemic or haemorrhagic) with hemiplegic motor deficit(s) due to stroke as diagnosed by CT or MRI.
  • Post stroke of at least 6 months with stable neurological status.
  • Age 21 to 80 years of age.
  • Hemiplegic pattern and shoulder abduction MRC motor power \> 2/5 and elbow extension \>2/5
  • Has a stable home abode and a carer/NOK to assist with donning of device and supervise home based exercise
  • MOCA \> or equal to 22/30
  • Able to give and sign informed consent at research site.
  • Able to speak English

Age in the registry: 21 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tan Tock Seng Hospital
Coordinator of this site? Confirm its status
SingaporeSingaporeUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.